Free tool
Diagnostics stocks
We cover 4 companies grouped under the Diagnostics theme. The median market value in the group is $7.83M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −67.4% to −9.6% across the middle 80 percent of the group, with a median of −53.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0K3W.L | Myriad Genetics, Inc. | $370.48M | Small cap | −48.77% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.66M | Micro cap | +7.14% |
| VRCI.L | Verici Dx plc | $6.99M | Micro cap | −57.14% |
| 2CUREX.ST | 2cureX AB (publ) | $1.34M | Micro cap | −71.79% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.